本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

7.22
-0.4900-6.36%
盘后7.390.1700+2.35%16:53 EDT
成交量:93.44万
成交额:675.13万
市值:7.32亿
市盈率:-7.05
高:7.70
开:7.55
低:7.06
收:7.71
数据加载中...
2025/03/06

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]